Your session is about to expire
← Back to Search
Motivation Skills Training (MST) for Schizophrenia (MST Trial)
N/A
Waitlist Available
Led By Alice Saperstein, PhD
Research Sponsored by Columbia University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and up to 14 weeks
Awards & highlights
MST Trial Summary
This trial will study the effects of a group-based skills training intervention aimed at improving motivation and goal attainment in 10 adults w/ serious mental illness. Assessments at baseline and treatment endpoint will measure changes in motivation, goal attainment and quality of life.
Who is the study for?
This trial is for adults aged 18-65 with a diagnosis of schizophrenia or schizoaffective disorder, who are stable enough to attend outpatient treatment and can speak English. It's not suitable for those outside this age range or without fluency in English.Check my eligibility
What is being tested?
The study tests Motivation Skills Training (MST), which is group therapy designed to help participants understand and manage their motivation better, aiming to improve goal-directed behavior over a period of approximately 12 weeks.See study design
What are the potential side effects?
Since MST involves psychological skills training rather than medication, traditional side effects like you'd see with drugs aren't expected. However, discussing mental health can sometimes be emotionally challenging.
MST Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline and up to 14 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and up to 14 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Goal Attainment Scaling (GAS)
Change in Motivation and Pleasure Scale (MAP)
Secondary outcome measures
Change in Heinrichs Carpenter Quality of Life Scale (QLS)
MST Trial Design
1Treatment groups
Experimental Treatment
Group I: Motivation Skills Training (MST)Experimental Treatment1 Intervention
Participants will complete a baseline assessment, receive weekly MST sessions in a group format for a duration of 12 weeks, and will then repeat the assessment battery from baseline as well as a satisfaction survey.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Motivation Skills Training (MST)
2023
N/A
~10
Find a Location
Who is running the clinical trial?
Columbia UniversityLead Sponsor
1,431 Previous Clinical Trials
2,460,823 Total Patients Enrolled
24 Trials studying Schizophrenia
3,447 Patients Enrolled for Schizophrenia
National Institute of Mental Health (NIMH)NIH
2,782 Previous Clinical Trials
2,689,099 Total Patients Enrolled
248 Trials studying Schizophrenia
89,416 Patients Enrolled for Schizophrenia
Alice Saperstein, PhDPrincipal InvestigatorColumbia University
1 Previous Clinical Trials
80 Total Patients Enrolled
1 Trials studying Schizophrenia
80 Patients Enrolled for Schizophrenia
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is eligibility for this study restricted to those over 80 years of age?
"This medical trial is designed for people of age between 18 and 65. For those younger or older, there are 90 trials available to the former group and 232 studies tailored towards the latter."
Answered by AI
Is this medical experiment currently open to participants?
"The clinicaltrials.gov website provides evidence that this medical trial is not presently enrolling patients; it was initially posted on May 30th 2023 and the last update occurred June 27th 2023. At present, there are over 460 other studies seeking participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger